Catalyst Wire Dossier Catalyst Wire Dossier

Lesinurad

lesinurad · Ardea Biosciences, Inc.
Drug timelines are a Plus or Pro feature.

4 regulatory and trial events tracked for Lesinurad, covering 2014-01-09 to 2021-11-04. Get the full timeline:

Most recent: Clinical Trial Update: A Phase 4 Safety and Efficacy Study to Evaluate Lesinurad 200 mg in Participants With Gout and Renal Impairment [Phase 4]

See pricing